Product Images Oxcarbazepine

This is a prescription medication named Oxcarbazepine, manufactured by Sun Pharma. It comes in the form of tablets of 600mg each, and the quantity provided is 100 HD2. The label provides the NDC number, manufacturing information, storage temperature range and directions for use. It also indicates that the medication must be kept out of reach of children. The medication has been packaged by RemedyRepack inc. located in Indiana, PA.*

Oxcarbazepine is a tablet with a dosage of 600 mg prescribed to be taken as per the directions provided in the package insert. The tablet is packaged by RemedyRepack nc. and has an NDC #: 70518-1027-02. The manufacturer of the tablet is Sun Pharma based in Cranbury, NJ 08512. The medication should be stored at temperatures between 20-25°C (83-77°F) with excursions permitted to 15-30°C (53-86°F) [See USP]. The expiration date and OT number are not available. It is advised to keep the medication out of the reach of children.*

Oxcarbazepine is a prescription drug sold in tablet form, with a strength of 600mg per tablet and quantity of 100 tablets per container. The product is packaged by RemedyRepack Inc. in Indiana, PA and its source NDC code is 62756-0185-88. The medication should be stored between 20-25°C (68-77°F) with permitted excursions to 15-30°C (53-86°F). The package insert should be consulted for directions on use, and the medication should be kept out of reach of children. The expiration date and OT# are not available. RX ONLY.*

This is a medication labeled "RX only" with 600mg Oxcarbazepine tablets, quantity of 1. The NDC number is 70518-1027-04, and it expires at an unspecified date. The medication is manufactured by Sun Pharma in Cranbury, NJ and packaged by RemedyRepack in Indiana, PA. The package insert should be referred to for usage directions. The medication should be stored between 20-25°C (83-77°F) with permissible excursions to 15-30°C (53-86°F) as per the United States Pharmacopeia guidelines. The source NDC number is stated as 62756-0185-88. It is important to keep this medication out of reach of children.*

OXcarbazepine is a medication available in the form of 600mg tablets. The package contains 30 tablets and is manufactured by Sun Pharma in Cranbury, NJ 08512. It is only available through prescription and should be kept out of reach of children. The directions for use are available on the package insert. The medication should be stored between 20-25°C (83-77°F) and excursions are permitted between 15-30°C (53-86°F) [See USP]. The medication is packaged by RemedyRepack Inc., Indiana, PA 15701, 724.465.8762.*

This is a plot showing Kaplan-Meier estimates of the exit rate by treatment group. The plot shows how long individuals from each group remained in the study without dropping out, with Oxcarbazepine and Placebo groups compared. The x-axis displays the time in days, whilst the y-axis displays the proportion of participants remaining in the study. The plot indicates a significant difference in the exit rate between the two groups, with the log-rank test p-value showing a very significant difference. The plot includes a legend that shows the treatment group; Oxcarbazepine and Placebo.*

The figure shows the Kaplan-Meier estimates of the first seizure event rate by treatment group. The graph includes the days from the first dose to the first seizure, with the treatment group on oxcarbazepine and placebo. The log-rank test resulted in a p-value of 0.046.*

This is a graph showing the Kaplan-Meier estimates of exit rate by treatment group. The exit rate is shown on the y-axis, with values ranging from 0 to 0.9. The x-axis shows time to exit in days. There are two treatment groups - HIGH and LOW - with their respective performance represented by different colored lines. A log-rank test was conducted and produced a p-value of 0.0001.*

This text describes the results of a study that compared the exit rates of two treatment groups. The Kaplan-Meier estimates of the exit rate for each group are displayed in Figure 4, and a log-rank test was performed with a p-value of 0.0001. The remaining text appears to be a series of gibberish and is not understandable.*